G2 Goldfields Inc
XTSX:GTWO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G2 Goldfields Inc
XTSX:GTWO
|
CA |
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
KR |
|
Shenwan Hongyuan Group Co Ltd
SZSE:000166
|
CN |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
C
|
Chayo Group PCL
SET:CHAYO
|
TH |
|
A
|
Aksharchem (India) Ltd
NSE:AKSHARCHEM
|
IN |
|
A
|
Alps Industries Ltd
NSE:ALPSINDUS
|
IN |
|
P
|
PC Direct Inc
KOSDAQ:051380
|
KR |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
|
A
|
Aspo Oyj
OMXH:ASPO
|
FI |
|
Suominen Oyj
LSE:0M1M
|
FI |
|
M
|
Moorim SP Co Ltd
KOSDAQ:001810
|
KR |
Balance Sheet
Balance Sheet Decomposition
G2 Goldfields Inc
G2 Goldfields Inc
Balance Sheet
G2 Goldfields Inc
| May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
16
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
16
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
2
|
16
|
|
| PP&E Net |
1
|
0
|
0
|
7
|
9
|
10
|
20
|
12
|
16
|
27
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
27
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
0
-61%
|
0
-44%
|
7
+2 882%
|
9
+24%
|
12
+34%
|
21
+76%
|
14
-34%
|
18
+29%
|
43
+143%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-79%
|
0
+24%
|
0
+267%
|
0
+81%
|
1
+95%
|
1
+40%
|
1
-24%
|
1
-6%
|
2
+109%
|
|
| Equity | |||||||||||
| Common Stock |
26
|
26
|
26
|
33
|
34
|
36
|
46
|
52
|
58
|
84
|
|
| Retained Earnings |
29
|
31
|
31
|
32
|
32
|
32
|
33
|
46
|
49
|
54
|
|
| Additional Paid In Capital |
4
|
6
|
6
|
6
|
6
|
6
|
7
|
9
|
10
|
12
|
|
| Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
|
| Total Equity |
1
N/A
|
0
-55%
|
0
-55%
|
7
+4 044%
|
8
+21%
|
11
+30%
|
20
+79%
|
13
-34%
|
17
+31%
|
41
+145%
|
|
| Total Liabilities & Equity |
1
N/A
|
0
-61%
|
0
-44%
|
7
+2 882%
|
9
+24%
|
12
+34%
|
21
+76%
|
14
-34%
|
18
+29%
|
43
+143%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
31
|
50
|
67
|
107
|
127
|
142
|
183
|
|